ConferenceClin Exp Rheumatol · February 2026
OBJECTIVES: We performed a multi-institutional retrospective review of patients treated for juvenile dermatomyositis (JDM)-associated calcinosis to analyse the association between treatment outcomes and patient, disease, and treatment characteristics. METH ...
Full textLink to itemCite
ConferenceJ Eur Acad Dermatol Venereol · July 2023
BACKGROUND: The Localized Scleroderma Quality of Life Instrument (LoSQI) is a disease-specific patient-reported outcome (PRO) measure designed for children and adolescents with localized scleroderma (LS; morphea). This tool was developed using rigorous PRO ...
Full textLink to itemCite
ConferenceArthritis Care Res (Hoboken) · December 2021
OBJECTIVE: Down syndrome-associated arthritis (DA) is underrecognized, and current therapies used for juvenile idiopathic arthritis (JIA) appear to be poorly tolerated and less effective in patients with DA. The objective of this study was to characterize ...
Full textLink to itemCite
ConferencePediatr Rheumatol Online J · February 23, 2021
BACKGROUND: Mental health disorders are common in youth with rheumatological disease yet optimal intervention strategies are understudied in this population. We examined patient and parent perspectives on mental health intervention for youth with rheumatol ...
Full textLink to itemCite
ConferenceArthritis Care Res (Hoboken) · September 2017
OBJECTIVE: To determine the prevalence and risk factors for hospitalization with dermatomyositis and assess inpatient burden of dermatomyositis. METHODS: Data on 72,651,487 hospitalizations from the 2002-2012 Nationwide Inpatient Sample, a 20% stratified s ...
Full textLink to itemCite